Compared to other weight loss drugs, using GLP-1 agonists increases the risk of pancreatitis (inflammation of the pancreas) by 9 times, bowel obstruction (blockage of the small or large intestines) by 4.5 times, and gastroparesis (a condition that slows or stops the movement of food from the stomach to the small intestine) by 3.6 times
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around individual genetic variations in antioxidant enzyme pathways and cellular metabolism, supporting a more informed discussion about whether supplemental glutathione aligns with a person's metabolic profile
Clinical studies show patients lose 1522% of their body weight on semaglutide sustainable weight loss results comparable to what was previously seen only with weight loss surgery
SCALE, Satiety and Clinical Adiposity-Liraglutide
They reduce their intake without following a structured schedule
Val the membership manager was great to work with
